Citadel Realty (502445)

Score breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 1/2 · Dividend: 0/1

Key Financials

Strengths

• ROE of 10.96% and ROCE of 10.61% suggest the existing asset base is not being destroyed despite tiny scale.
• Piotroski F-Score of 7/9 points to reasonably sound short-term financial health, especially for a small-cap.
• Stock is more than 50% below its 52-week high of ₹76.45, so much pessimism may already be priced in.
• A small dividend yield of 1.28% provides some minor compensation while waiting for a turnaround.

Concerns

• Zero sales growth and zero profit growth; latest quarter net profit is ₹0 Cr on only ₹1 Cr of sales—no demonstrated earning power.
• P/E of 24.89 and PEG of 2.48 are unattractive for a stagnant business.
• Price-to-book of 2.44 offers no Graham-style margin of safety, since book value is just ₹14.94 against a price of ₹36.41.
• Debt/equity and promoter holding are not available, leaving balance-sheet risk and ownership alignment unclear.

AI Analysis

When I look at Citadel Realty, I see a small real estate operator with a market cap of just ₹30 crore and a stock quoting at ₹36.41. Mr. Market has been unkind—shares are down from ₹76.45 to near the 52-week low. That alone doesn't make it cheap. Benjamin Graham taught me to buy with a margin of safety, and I don't see one here. The company earns roughly 11% on equity and on capital employed; that is mediocre, and with zero sales growth and zero profit growth, it has no momentum. The latest quarter's net profit is literally ₹0 crore on ₹1 crore of sales. A P/E of 24.89 for a no-growth business is far too rich, and PEG of 2.48 makes sense only if you expect future growth; I don't have evidence. Book value is ₹14.94, so the market is asking 2.44 times book for a developer with no visible pipeline. The Piotroski F-score of 7/9 suggests short-term financial health is okay, but that is not a moat. In real estate, cash flows are lumpy and cyclical; this looks like a cyclical at the bottom, not a growing franchise. The 1.28% dividend is a small consolation. Without debt details, promoter holding details, or project pipeline, I cannot value this as an asset play either. I would need the price well below book and clearer evidence of earning power before I part with my money. For now, this is a 'no thanks' at ₹36.41.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer